Orthobiologics Market Analysis & Future Growth Prospects to 2022 | Key Segments, Benefits

Orthobiologics Market Analysis & Future Growth Prospects to 2022 | Key Segments, Benefits

Orthobiologics Market Overview:
Between 2017 and 2022, the Orthobiologics Market is estimated to increase at a CAGR of 5.4 percent. The orthobiologics market is being driven by factors such as the rising burden of orthopaedic injuries, the rising incidence of sports injuries and road accidents, the rising incidence of spinal fusion surgeries, risk factors associated with the ageing population, obesity rate, and high incidence of musculoskeletal disorders, and the growing patient preference for minimally invasive procedures.
Product launches, strategic acquisitions, agreements, contracts, partnerships, collaborations, and market expansions are among the growth strategies used by market players to strengthen their product portfolios and maintain a competitive position in the orthobiologics market, according to an analysis of market developments between 2014 and 2017. Product showcases, product launches, collaborations, and agreements were the most often used growth tactics among these company strategies.
Request For Free Sample
@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162747970

Orthobiologics Market Stakeholders
Orthobiologics Product Manufacturing Companies
Product Suppliers, Distributors, and Channel Partners
Hospitals and Ambulatory Care Centers
Orthopedic and Dental Clinics
Research Laboratories and CROs
Research and Academic Institutes
National and International Regulatory Authorities
Government and Non-government Organizations
Market Research Firms

Get Sample PDF Brochure
@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162747970

Market Segmentation:
Based on product, the viscosupplementation products segment is estimated account for the largest segment of the Orthobiologics Market in 2017

On the basis of product, the orthobiologics market is segmented into allografts, synthetic orthobiologics, plasma-rich protein (PRP), bone marrow aspirate concentrate (BMAC), demineralized bone matrices (DBM), bone morphogenic protein (BMP), and viscosupplementation products. The viscosupplementation products segment is expected to account for largest share of the orthobiologics market in 2017. The large share of this segment can be attributed to the increasing incidence of osteoarthritis of the knee and hip joints among the baby boomer population and lower cost of viscosupplementations.

Based on application, the osteoarthritis and degenerative arthritis segment expected to account for the largest share of the Orthobiologics market in 2017

Based on application, the orthobiologics market is segmented into fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft tissue injuries, and maxillofacial & dental applications. The osteoarthritis and degenerative arthritis segment is estimated to command the largest share of the global orthobiologics market in 2017. The large share of this segment is mainly due to factors such as the significant rise in target patient population across major markets, rising public awareness related to clinical side effects associated with oral medications for pain management, clinical advancements in OA management methodologies, robust healthcare infrastructure & facilities for specific joint replacement surgeries across major markets, and growing clinical evidence validating the efficacy of biologics in OA treatment.

Key Players:

The major players in the Orthobiologics Market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.

Will You Have Any Questions About This Report? Please Contact Us On link
@ https://www.marketsandmarkets.com/Market-Reports/orthobiologics-market-162747970.html
About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Rohan
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
Email: sales@marketsandmarkets.com